Early-onset Alzheimer's shows heavier and faster-spreading tau pathology than late-onset disease
- Researchers compared tau PET imaging at baseline and over time in amyloid-positive, cognitively impaired people with early-onset or late-onset Alzheimer's disease, drawing on two separate cohort studies.
- After accounting for amyloid burden and clinical stage, early-onset patients had greater tau retention, wider brain involvement and quicker accumulation.
- Tau signal tracked amyloid levels, cognition and daily function more closely in the early-onset group, pointing to tau as a main driver of decline and suggesting treatment targets may differ by age of onset.
💡 Points Based on the abstract
Before anyone reads this as proof tau is the better target, ask whether PET signal is causal burden or just a tighter readout of disease stage. Cross-sectional correlations can't separate the two. Still, if tau slopes are steeper in early onset, that cohort could power a smaller, faster trial of an anti-tau agent.
Distinct tau PET dynamics in early versus late age-of-onset Alzheimer’s disease ↗